- Home
- EVOK vs NBY Comparison
EVOK vs NBY Comparison
Compare EVOK & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- NBY
- Stock Information
- Founded
- EVOK 2007
- NBY 2000
- Country
- EVOK United States
- NBY United States
- Employees
- EVOK N/A
- NBY N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- NBY
- Sector
- EVOK Health Care
- NBY
- Exchange
- EVOK Nasdaq
- NBY Nasdaq
- Market Cap
- EVOK 7.7M
- NBY 3.8M
- IPO Year
- EVOK 2013
- NBY 2007
- Fundamental
- Price
- EVOK $3.85
- NBY $0.62
- Analyst Decision
- EVOK
- NBY Strong Buy
- Analyst Count
- EVOK 0
- NBY 1
- Target Price
- EVOK N/A
- NBY $0.85
- AVG Volume (30 Days)
- EVOK 7.2M
- NBY 40.6K
- Earning Date
- EVOK 08-12-2025
- NBY 08-12-2025
- Dividend Yield
- EVOK N/A
- NBY N/A
- EPS Growth
- EVOK N/A
- NBY N/A
- EPS
- EVOK N/A
- NBY 0.57
- Revenue
- EVOK $11,594,083.00
- NBY $9,781,000.00
- Revenue This Year
- EVOK $57.82
- NBY $23.91
- Revenue Next Year
- EVOK $59.12
- NBY $32.05
- P/E Ratio
- EVOK N/A
- NBY $1.38
- Revenue Growth
- EVOK 89.89
- NBY 20.52
- 52 Week Low
- EVOK $1.94
- NBY $0.36
- 52 Week High
- EVOK $12.32
- NBY $1.01
- Technical
- Relative Strength Index (RSI)
- EVOK 46.17
- NBY 45.71
- Support Level
- EVOK $4.26
- NBY $0.63
- Resistance Level
- EVOK $4.70
- NBY $0.68
- Average True Range (ATR)
- EVOK 0.43
- NBY 0.05
- MACD
- EVOK -0.15
- NBY -0.01
- Stochastic Oscillator
- EVOK 4.80
- NBY 13.33
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.